Articles from USANA Health Sciences, Inc.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that fourth quarter and fiscal year 2024 results will be released after the close of market on Tuesday, February 25, 2025. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, February 26, 2025 at 11:00 a.m. Eastern Time.

USANA Health Sciences, Inc. (NYSEUSNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that Doug Hekking, Chief Financial Officer, will participate in a fireside chat and host one-on-one meetings with investors at the ICR Conference in Orlando, FL on January 13-14, 2025. The fireside chat will begin at 8:00 AM ET on January 13, 2025.

USANA Health Sciences, Inc. (NYSEUSNA) (the “Company,” “USANA”), today announced its acquisition of a 78.8% controlling ownership stake in Hiya Health Products, LLC (“Hiya”), a leading direct-to-consumer provider of high-quality children’s health & wellness products. The $205 million cash transaction closed on December 23, 2024 and is anticipated to be accretive to USANA’s 2025 adjusted EBITDA. For the last twelve months ended September 30, 2024 (unaudited), Hiya generated net sales of $103 million, net income of $19 million, and adjusted EBITDA of $22 million. As of September 30, 2024, Hiya had more than 200,000 customers.

USANA Health Sciences, Inc. (NYSEUSNA) today announced financial results for its fiscal third quarter ended September 28, 2024.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that third quarter 2024 results will be released after the close of market on Tuesday, October 22, 2024. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, October 23, 2024 at 11:00 a.m. Eastern Time.

USANA Health Sciences, Inc. (NYSEUSNA) today announced financial results for its fiscal second quarter ended June 29, 2024.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that second quarter 2024 results will be released after the close of market on Tuesday, July 23, 2024. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, July 24, 2024 at 11:00 a.m. Eastern Time.

USANA Health Sciences, Inc. (NYSEUSNA) today announced financial results for its fiscal first quarter ended March 30, 2024.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that first quarter 2024 results will be released after the close of market on Tuesday, April 30, 2024. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, May 1, 2024 at 11:00 a.m. Eastern Time.

USANA Health Sciences, Inc. (NYSEUSNA) today announced financial results for its fiscal fourth quarter and fiscal year ended December 30, 2023.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that fourth quarter and fiscal year 2023 results will be released after the close of market on Tuesday, February 6, 2024. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, February 7, 2024 at 11:00 a.m. Eastern Time.

USANA Health Sciences, Inc. (NYSEUSNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that it will host investor meetings and a fireside chat presentation at the ICR Conference in Orlando, FL on January 8-9, 2024. Doug Hekking, Chief Financial Officer, will be participating in the fireside chat, scheduled to begin at 10:30 AM ET on January 8, 2024.

USANA Health Sciences, Inc. (NYSEUSNA) today announced financial results for its fiscal third quarter ended September 30, 2023.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that third quarter results will be released after the close of market on Tuesday, October 24, 2023. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, October 25, 2023 at 11:00 a.m. Eastern Time.

USANA Health Sciences, Inc. (NYSEUSNA) today announced financial results for its fiscal second quarter ended July 1, 2023.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that second quarter results will be released after the close of market on Tuesday, July 25, 2023. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, July 26, 2023 at 11:00 a.m. Eastern Time.

USANA Health Sciences, Inc. (NYSEUSNA) today announced its plans to expand into India in the second half of 2023. Expansion into India increases the Company’s global footprint to 25 markets.

USANA Health Sciences, Inc. (NYSEUSNA) today announced financial results for its fiscal first quarter ended April 1, 2023.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that first quarter results will be released after the close of market on Tuesday, April 25, 2023. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, April 26, 2023 at 11:00 a.m. Eastern Time.

USANA Health Sciences, Inc. (NYSEUSNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that Doug Hekking, Chief Financial Officer, is scheduled to participate in upcoming investor conferences.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that consistent with the Company’s planned succession strategy, Kevin Guest, USANA’s Chief Executive Officer (CEO) since 2015 and Chairman of the Board since 2020, will transition to the role of Executive Chairman of the Company, effective July 1, 2023. At that time, Jim Brown, USANA’s current President, will be named CEO of the Company.

USANA Health Sciences, Inc. (NYSEUSNA) today announced financial results for its fiscal fourth quarter and full year ended December 31, 2022.

USANA Health Sciences, Inc. (NYSEUSNA) today announced preliminary fiscal year 2022 results and initial guidance for fiscal year 2023 ahead of its presentation at the 25th Annual ICR Conference.

USANA Health Sciences, Inc. (NYSEUSNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that Doug Hekking, Chief Financial Officer, will present and host one-on-one meetings with investors at the ICR Conference in Orlando, FL on January 9-10, 2023. The presentation will begin at 3:30PM ET on January 10, 2023.

USANA Health Sciences, Inc. (NYSEUSNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that Doug Hekking, Chief Financial Officer, will present and host one-on-one meetings with investors at the Sidoti December Virtual Investor Conference, taking place on December 7-8, 2022.

USANA Health Sciences, Inc. (NYSEUSNA) today announced the acquisition of two companies—Rise Bar and Oola.

USANA Health Sciences, Inc. (NYSEUSNA) today announced financial results for its fiscal third quarter ended October 1, 2022.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that third quarter results will be released after the close of market on Tuesday, October 25, 2022. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s website (http://ir.usana.com) under the Investor Relations section of the site. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, October 26, 2022 at 11:00 a.m. Eastern Time.

USANA Health Sciences, Inc. (NYSEUSNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that Doug Hekking, Chief Financial Officer, will be presenting at the Jefferies Virtual Fitness & Wellness Summit on Monday, September 12, 2022.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that J. Scott Nixon, CPA has rejoined the Company’s Board of Directors effective July 25, 2022. Mr. Nixon previously served as an independent director of the Company from October 2017 through May 2019, before departing from the Board to fulfill a three-year voluntary leadership assignment for The Church of Jesus Christ of Latter-day Saints in Brazil. With Mr. Nixon’s appointment to the Board as an independent director, the USANA board now has eight members, seven of whom are independent.

USANA Health Sciences, Inc. (NYSEUSNA) today announced financial results for its fiscal second quarter ended July 2, 2022.

USANA Health Sciences, Inc. (NYSEUSNA) today announced preliminary results for the second quarter ended July 2, 2022, and provided an updated outlook for fiscal year 2022. The Company anticipates that second quarter 2022 net sales will be approximately $265 million, which compares with $337 million in the prior-year period. Earnings per share for the quarter are expected to be approximately $1.05, which compares with $1.87 during the second quarter of 2021.

USANA Health Sciences, Inc. (NYSEUSNA) today announced financial results for its fiscal first quarter ended April 2, 2022.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that first quarter results will be released after the close of market on Tuesday, April 26, 2022. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s website (http://ir.usana.com) under the Investor Relations section of the site. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, April 27, 2022 at 11:00 a.m. Eastern Time.

USANA Health Sciences, Inc. (NYSEUSNA) today announced financial results for its full year and fiscal fourth quarter ended January 1, 2022.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that fourth quarter and FY 2021 results will be released after the close of market on Tuesday, February 8, 2022. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s website (http://ir.usana.com) under the Investor Relations section of the site. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, February 9, 2022 at 11:00 a.m. Eastern Time.

USANA Health Sciences, Inc. (NYSEUSNA) today announced financial results for its fiscal third quarter ended October 2, 2021, which were modestly ahead of the preliminary outlook the Company provided on September 16, 2021.

USANA Health Sciences, Inc. (NYSEUSNA) today announced the appointment of Xia Ding to the company’s board of directors effective October 11, 2021. Ms. Ding currently serves as Vice President of e-commerce Asia Pacific and Latin America at Nike and is well-regarded as an e-commerce and digital business leader. She has served in various management roles at several global online and omnichannel retailers, including Nike, JD.com and Hanesbrands. With the addition of Ms. Ding to the board as an independent director, the USANA board now has eight members, six of whom are independent.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that third quarter 2021 results will be released after the close of market on Tuesday, October 26, 2021. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s website (http://ir.usana.com) under the Investor Relations section of the site. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, October 27, 2021 at 11:00 a.m. Eastern Time.

USANA Health Sciences, Inc. (NYSEUSNA) today announced preliminary third quarter results and updated outlook for fiscal year 2021. The Company currently anticipates third quarter 2021 net sales to range between $265 and $270 million, which compares with $299 million in the prior-year period. Earnings per share for the quarter are expected to range between $1.28 and $1.33, which compares with $1.44 during the third quarter of 2020.

USANA Health Sciences, Inc. (NYSEUSNA) today announced record financial results for its fiscal second quarter ended July 3, 2021.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that second quarter results will be released after the close of market Tuesday, July 27, 2021. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s website (http://ir.usana.com) under the Investor Relations section of the site. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, July 28, 2021 at 11:00 a.m. Eastern Time.

USANA Health Sciences, Inc. (NYSEUSNA) today announced financial results for its fiscal first quarter ended April 3, 2021.

USANA Health Sciences, Inc. (NYSEUSNA) today announced that first quarter results will be released after the close of market Tuesday, April 27, 2021. Shortly following the issuance of the Company’s earnings release, the Company will post a “Management Commentary, Results and Outlook” document on the Company’s website (http://ir.usana.com) under the “Investor Relations” section of the site. The following morning at 11:00 a.m. Eastern Time, USANA will hold a conference call to discuss this announcement with analysts and institutional investors.